FCM
Farallon Capital Management Portfolio holdings
AUM $21.3B
1-Year Return
23.12%
This Quarter Return
+2.95%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$12B
AUM Growth
+$2B
(+20%)
Cap. Flow
+$1.99B
Cap. Flow
% of AUM
16.6%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
107
New
26
Increased
43
Reduced
12
Closed
21
Top Buys
| 1 |
COL
Rockwell Collins
COL
|
+$387M |
| 2 |
Keurig Dr Pepper
KDP
|
+$387M |
| 3 |
MON
Monsanto Co
MON
|
+$374M |
| 4 |
LOGM
LogMein, Inc.
LOGM
|
+$202M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$182M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$307M |
| 2 |
AABA
Altaba Inc. Common Stock
AABA
|
+$244M |
| 3 |
AB InBev
BUD
|
+$164M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$163M |
| 5 |
Huntsman Corp
HUN
|
+$80.7M |
Sector Composition
| 1 | Technology | 25.94% |
| 2 | Healthcare | 17.57% |
| 3 | Communication Services | 16.49% |
| 4 | Financials | 13.71% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Liberty Global Class A
LBTYA
$4.05B
| $148M | 1.02% |
4,713,926
+1,443,746
| +44% | +$45.2M |
|
27
Fidelity National Information Services
FIS
$35B
| $147M | 1.02% |
1,527,538
-503,838
| -25% | -$48.5M |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $147M | 1.02% |
4,086,300
+150,000
| +4% | +$5.39M |
|
29
Gilead Sciences
GILD
$140B
| $137M | 0.95% |
+1,820,000
| New | +$137M |
|
|
ABLX
30
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $134M | 0.93% |
2,450,000
+100,000
| +4% | +$5.46M |
|
31
AstraZeneca
AZN
$242B
| $125M | 0.86% |
3,565,000
-200,000
| -5% | -$6.99M |
|
32
IAC Inc
IAC
$2.89B
| $112M | 0.77% |
+4,000,716
| New | +$112M |
|
|
TWX
33
DELISTED
Time Warner Inc
TWX
| $96.5M | 0.67% |
1,020,000
-3,245,000
| -76% | -$307M |
|
34
Biogen
BIIB
$21B
| $93.1M | 0.64% |
340,000
-200,000
| -37% | -$54.8M |
|
35
Ascendis Pharma
ASND
$11.8B
| $84.2M | 0.58% |
+1,286,800
| New | +$84.2M |
|
36
FibroGen
FGEN
$47.9M
| $79.3M | 0.55% |
68,700
+2,400
| +4% | +$2.77M |
|
|
XL
37
DELISTED
XL Group Ltd.
XL
| $74.9M | 0.52% |
+1,355,000
| New | +$74.9M |
|
38
Enanta Pharmaceuticals
ENTA
$159M
| $74M | 0.51% |
915,000
-10,000
| -1% | -$809K |
|
|
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
| $71.8M | 0.5% |
+1,040,000
| New | +$71.8M |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $71.7M | 0.5% |
445,000
+45,000
| +11% | +$7.25M |
|
41
Iovance Biotherapeutics
IOVA
$821M
| $70.1M | 0.49% |
4,150,000
+2,283,100
| +122% | +$38.6M |
|
|
HRG
42
DELISTED
HRG Group, Inc.
HRG
| $66.6M | 0.46% |
4,040,000
+2,898,000
| +254% | +$47.8M |
|
|
ZGNX
43
DELISTED
Zogenix, Inc.
ZGNX
| $63.1M | 0.44% |
1,576,000
+726,000
| +85% | +$29.1M |
|
|
XLRN
44
DELISTED
Acceleron Pharma Inc.
XLRN
| $54.8M | 0.38% |
1,401,000
+313,000
| +29% | +$12.2M |
|
45
Qualcomm
QCOM
$174B
| $53.2M | 0.37% |
960,000
+170,217
| +22% | +$9.43M |
|
46
Amicus Therapeutics
FOLD
$2.38B
| $52.4M | 0.36% |
3,481,000
+700,000
| +25% | +$10.5M |
|
47
Bunge Global
BG
$16.1B
| $51M | 0.35% |
690,000
+585,000
| +557% | +$43.3M |
|
|
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $50.7M | 0.35% |
1,039,278
+175,546
| +20% | +$8.57M |
|
|
ARRY
49
DELISTED
Array Biopharma Inc
ARRY
| $50.5M | 0.35% |
+3,095,000
| New | +$50.5M |
|
50
XPO
XPO
$15.8B
| $48.4M | 0.33% |
1,373,412
+1,113,187
| +428% | +$39.2M |
|